Results reported as Diagnosis/ Anti-HIV ½ Ab positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Anti-HLTV-I Ab positive, negative or not Diagnosis Supplemental done; measured in U/mL Results reported as Anti-Interferon Ab Diagnosis/ positive, negative or not Supplemental Binding Safety done; measured in U/mL. Results reported as positive, negative or not done; measured in U/mL; Anti-Interferon Ab Sample titers, or ranges: Diagnosis/ Supplemental Neutralizing negative (<1:20); Safety moderate positive (>1:20 to <1:100) and highly positive (>1:100). Results reported as Anti-JC VAb (virus Diagnosis/ positive, negative or not Supplemental antibodies) Safety done; measured in U/mL Results reported as Diagnosis/ Anti-microsomal Ab positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Diagnosis/ Anti-mycoplasma Ab positive, negative or not Supplemental Safety done; measured in U/mL Results reported as AntiNeutrophil Diagnosis/ positive, negative or not Supplemental Cytoplasmic Antibodies Safety done Results reported as Anti-nuclear Ab positive, negative or not Diagnosis Supplemental done; measured in titer Results reported as Diagnosis/ Anti-SSA positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Diagnosis/ Anti-SSB positive, negative or not Supplemental Safety done; measured in U/mL Results reported as Antithrombin Activity Diagnosis/ positive, negative or not Supplemental (AT-III) Safety done; measured in U/mL Results reported as Diagnosis/ Anti-thyroglobulin Ab positive, negative or not Supplemental Safety done; measured in U/mL Some laboratories report Diagnosis/ Anti-thyroid Ab Supplemental as anti-thyroid peroxidase Safety Results reported as Diagnosis/ Anti-VZV Ab positive, negative or not Supplemental Safety done; measured in U/mL Arterial Blood Gases Measured in mmHg Safety Supplemental
Anti-HIV ½ Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-HLTV-I Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis Supplemental Anti-Interferon Ab Binding Results reported as positive, negative or not done; measured in U/mL. Diagnosis/ Safety Supplemental Anti-Interferon Ab Neutralizing Results reported as positive, negative or not done; measured in U/mL; Sample titers, or ranges: negative (<1:20); moderate positive (>1:20 to <1:100) and highly positive (>1:100). Diagnosis/ Safety Supplemental Anti-JC VAb (virus antibodies) Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-microsomal Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-mycoplasma Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental AntiNeutrophil Cytoplasmic Antibodies Results reported as positive, negative or not done Diagnosis/ Safety Supplemental Anti-nuclear Ab Results reported as positive, negative or not done; measured in titer Diagnosis Supplemental Anti-SSA Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-SSB Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Antithrombin Activity (AT-III) Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-thyroglobulin Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Anti-thyroid Ab Some laboratories report as anti-thyroid peroxidase Diagnosis/ Safety Supplemental Anti-VZV Ab Results reported as positive, negative or not done; measured in U/mL Diagnosis/ Safety Supplemental Arterial Blood Gases Measured in mmHg Safety Supplemental
F1287_Laboratory_Test_Recommendations.docx